Page 10 - BB Neuromedicine Highlights 2019

asTroCyTe pharma- Texas Health Sciences Center Astrocyte Pharmaceuticals of its concussion symptoms
CeuTiCals seT To Begin in San Antonia. However, has now acquired significant treatment in 2020. Based on
human drug Trials Astrocyte Pharmaceuticals startup funding from a variety drug trials in laboratory mice,
James Lechleiter, co-found- was not founded until 2014. of sources. Astrocyte Pharmaceuticals
er of Astrocyte Pharmaceu- Lechleiter partnered with In addition to $2.3 million has seen promising results.
ticals actually discovered William Korinek, former VP of obtained during pre-A round When mice receive the
the company’s concussion Research and Development funding, Astrocyte Pharma- concussion symptoms treat-
symptoms treatment drug Business Operations at Pfizer. ceuticals recently received ment within an hour of blunt
over a decade ago. The The two decided to begin their a $3 million grant from NIH. trauma, positive effects are
original research began while own start-up, and things have Because of this ,the company evident. If the human trials
he was at the University of taken off since. plans to begin Phase I trials show the same effects, Astro-